NUR 550 Topic 4 DQ 2: data collection and T-phases

This prompt contains four separate instructions and they are not equally weighted. You are asked to (1) identify a data collection tool for your own project, (2) consider a barrier that could arise while collecting that data, (3) identify the best type of translational research to address that barrier and justify the choice, and (4) describe strategies for explaining that type and building collaborative support. Move three is where the grade is decided, and it is the move most posts skip without noticing — because “type of translational research” is read as a stylistic flourish rather than as a request for a specific phase on a named continuum. Note also that “your research” is not hypothetical here: it means the PICOT you are carrying through this course's evidence-based practice proposal sequence, so the tool and the barrier both have to be plausible for that specific population.

It is a request for a phase. Translational research is conventionally described as a spectrum running from basic discovery through to population health — the T0 to T4 labelling, or NCATS's named stages from basic and preclinical research through clinical research, clinical implementation and public health. Saying “I would use translational research to close the gap between evidence and practice” names no phase and therefore answers nothing: that sentence is true of the entire spectrum. Naming T3 and saying why this barrier is an implementation problem rather than an efficacy problem is the whole of the answer. Courses differ on the labelling — some teach T0 through T4, others use NCATS's named stages, and a few use the older T1/T2 split alone. Use whichever vocabulary your own materials use, and use it consistently; the marker is looking for the placement, not for a particular numbering scheme.

The barrier you choose in move two dictates the phase in move three, so pick the barrier deliberately:

Move one deserves more than a category. “A survey” is not a data collection tool; the Braden Scale, the PHQ-9, a structured chart-abstraction form with defined fields, or a named readmission audit tool is. Whatever you name, say one thing about its reliability or validity in the population in your PICOT — the course objectives for this topic are explicitly about distinguishing reliability from validity, so an instrument mentioned without either is a mark left on the table. Borrowing a validated instrument and then altering its items, which is common in practice projects, forfeits the psychometrics you borrowed it for; if you plan to adapt one, say so and say what that costs you. A chart-abstraction form counts as a named tool only if you can say what its fields are and who fills them in.

Move four is asking for implementation strategies, and there is an established vocabulary for them. The ERIC compilation names 73 discrete strategies, so you can be concrete where most posts are vague: identify and prepare champions, conduct educational outreach, build a coalition, audit and provide feedback, alter staff workflows. Pair one or two of those with the domain of resistance you actually expect — CFIR sorts that into the innovation itself, the outer setting, the inner setting, the individuals involved, and the implementation process. “I would communicate effectively with stakeholders” names neither a strategy nor a barrier and is the sentence to cut. Audit and feedback, for instance, addresses fidelity rather than willingness, so it is the wrong choice if the real obstacle is that nobody believes the change is worth making.